This content is machine translated RA in over 70s bDMARDs and JAK inhibitors with lower risk of infection compared to baseline therapy. In clinical practice, older rheumatoid arthritis patients tend to receive treatment with biologics (bDMARDs) less frequently than younger patients, although the use of conventional basic therapeutics is often not appropriate…
View Post 4 min This content is machine translated Axial spondyloarthritis The road to diagnosis is still far too long Inflammatory chronic back pain is an indication of possible axial spondyloarthritis. It is a major challenge for primary care physicians to identify those with axSpA among the many back pain…
View Post 5 min This content is machine translated Biologics and JAK inhibitors New insights for RA therapy There are now four approved JAK inhibitors in Europe: tofacitinib, baricitinib, upadacitinib and filgotinib. While there has not been much news to report on the first two in the past…
View Post 5 min This content is machine translated Fertility and rheumatism Risk pregnancy It has been known for several years that women with rheumatoid arthritis (RA) and systemic lupus erythematosus (SLE) have fewer children than they would like to have compared to women…
View Post 4 min This content is machine translated Systemic lupus erythematosus (SLE) Patients with lupus nephritis benefit from additive therapy option The current EULAR guidelines recommend anti-B cell therapy with belimumab as an additive to standard therapy in systemic lupus erythematosus. Recently published trial data now show that belimumab also has…
View Post 10 min This content is machine translated Rheumatism 2021 News from basic research Some important and interesting studies in the field of rheumatology in the last year are summarized. As in all fields, technical and analytical capabilities are accelerating exponentially in basic research.… CME-Test
View Post 5 min This content is machine translated Rheumatoid arthritis Halting joint destruction through early use of DMARDs Early adequate therapy of rheumatoid arthritis (RA) is of central importance for the entire further course of the disease, current guidelines conclude. After diagnosis, the indication for disease-modifying therapy should…
View Post 4 min This content is machine translated Axial spondyloarthritis How can diagnostic delay be avoided? Inflammatory chronic back pain is an indication of possible axial spondyloarthritis. For primary care physicians, identifying those with axial spondyloarthritis among the many back pain patients is a major challenge.…
View Post 5 min This content is machine translated Psoriasis vulgaris Patient-adapted biologics therapy – What does the new S3 guideline say? Of particular note is the update to the recommendations on the delivery of systemic therapy. Newly approved active ingredients were integrated, and there is also a special focus on the…
View Post 3 min This content is machine translated Multiple sclerosis Effective treatment strategies right from the start – opportunities, risks, benefits Treatment of multiple sclerosis is aimed at reducing relapses, lowering disease activity, and slowing the progression of the disease and increase in disability. Both course and long-term therapy with e.g.…
View Post 4 min This content is machine translated Biologics treatment for psoriasis Anti-IL17 therapy over time The fact that IL17 inhibitors are characterized by a rapid onset of action has now been empirically proven several times and is also reflected in a recent head-to-head study. Looking…
